In the past several weeks we have seen different types of abortion bans moving through state legislatures, and in some cases getting signed by governors into law. It is important to note that none of these bans have taken effect; abortion is still legal in all fifty states. But these bills point to a troubling trend in reproductive rights. The national conversation on abortion access seems to have swung wildly in the direction of the anti-choice movement.
Trump Administration Proposal Redefines Poverty to Raise Health Care Costs for Middle-Class Families
For the second time in less than a month, the Trump administration has proposed obscure bureaucratic formula changes that will raise health care costs for 8.2 million people who buy private insurance using federal premium tax credits (PTCs). The latest move changes the definition of inflation that affects the federal poverty level (FPL), which is used to determine eligibility for many need-based programs.
In this testimony before the U.S. House of Representatives Energy and Commerce Committee on May 21, 2019, Frederick Isasi, Executive Director of Families USA, breaks down the problem with high drug prices and potential solutions under consideration by the committee. While high drug prices are a source of seemingly constant debate in Washington, D.C., for millions of America’s families, they are a painful and burdensome reality and can impact the basic necessities of life.
Drug companies consistently set high prices, which forces families to make impossible choices between their health care and other basic needs. Drug companies set exorbitant prices by design to maximize their profits, while making misleading claims that high prices simply fund innovative new drugs. Despite this gaming, our political system makes it easy for drug companies to continue exploitative pricing. This piece explains how our current drug pricing system leads to unaffordable prescription drugs, and ultimately harms people’s health.
On April 18, 2019, the Trump Administration finalized the Notice of Benefit and Payment Parameters for 2020 (NBPP). This rule will govern health insurance marketplaces and set the framework for insurance companies to propose plans and premium rates for 2020. Consumer advocates achieved several important victories in the final 2020 NBPP. Contrarily, the final rule also establishes harmful changes that will decrease access to high-quality, affordable coverage and care for families across the country.
Families USA, in partnership with American Academy of Family Physicians, American Benefits Council, American Federation of State, Country, and Municipal Employees, American Federation of Teachers, First Focus, and Pacific Business Group on Health, is launching Consumers First: The Alliance to Make the Health Care System Work for Everyone.
Families USA submitted the attached letter to U.S. House of Representatives Leadership in support of H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act.
Maryland’s Easy Enrollment Health Insurance Program: An Innovative Approach to Covering the Eligible Uninsured
The threatened repeal of the Affordable Care Act (ACA), major regulatory changes that affect ACA implementation, and a likely 2020 debate over Medicare for all have understandably captured the health policy community’s attention. As a result, relatively little discussion has recently focused on a basic problem that loomed quite large in the past: enrolling the eligible uninsured into available coverage.
This postcard advertises Families USA’s Oral Health for All story collection website, which provides an avenue for people with unmet oral health needs to get involved in changing oral health policy. Through the website, people can share what they’ve experienced, become more involved in oral health policy change, and get connected with advocacy resources.